Please use this identifier to cite or link to this item: http://repository.aaup.edu/jspui/handle/123456789/3403
Title: Understanding the Impact of EFQM and Risk Management on Organizational Resilience in Pharmaceutical Industry: The Role of Absorptive Capacity رسالة ماجستير
Other Titles: تطبيق أدوات ستة سيجما لتحسين نظام إدارة إستمرارية الأعمال في شركة القدس للمستحضرات الطبية.
Authors: Daraghmeh, Muath m$AAUP$Palestinian
Keywords: harmaceuticals Company,Six Sigma ,TQuality Managementools, Risk Management, Organizational Resilience
Issue Date: 2025
Publisher: AAUP
Abstract: This research examines the incorporation of European Foundation for Quality Management (EFQM) principles, risk management strategies, and absorptive capacity to improve organizational resilience within the Palestinian pharmaceutical industry. Despite the industry's susceptibility to regulatory constraints, financial limitations, and supply chain disruptions, there is a lack of research investigating the interactions of these factors in emerging economies. This research proposes a structured framework designed to address the unique challenges faced by the industry. A mixed-methods approach was utilized, integrating qualitative interviews with quantitative analysis. Data collection involved 10 in-depth interviews and 128 survey responses, which were analyzed using Partial Least Squares Structural Equation Modeling (PLS-SEM). The findings indicate that the implementation of EFQM, especially in the areas of leadership, strategy, and process management, greatly improves resilience. Risk management strategies are essential for the proactive identification and mitigation of disruptions. Absorptive capacity, although anticipated to influence these relationships, demonstrated a limited effect, indicating that external knowledge acquisition alone may not adequately improve resilience in the absence of robust internal integration mechanisms. The research highlights the importance of regulatory harmonization and collaboration among stakeholders to conform to international standards, including Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP). This study addresses a significant research gap, thereby enhancing the existing knowledge on resilience within emerging economies, specifically in the pharmaceutical industry. The proposed VI framework offers valuable insights for policymakers, industry leaders, and stakeholders to enhance resilience and competitiveness in a volatile global market.
Description: Master \ Quality Management
URI: http://repository.aaup.edu/jspui/handle/123456789/3403
Appears in Collections:Master Theses and Ph.D. Dissertations

Files in This Item:
File Description SizeFormat 
معاذ دراغمة.pdf6.49 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Admin Tools